Billing Details
Report Name

U.S. Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, Neutropenia, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Shopping Cart
Report Id License Type Price
FBI100990 $ 2850
Total $ 2850
Continue for Payment Method

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X